Azelby Robert insider trades
Azelby Robert has filed 17 Form 4s with the SEC that we hold, for ADC Therapeutics SA (ADCT) (Director), Cardinal Health INC (CAH) (Director), TERN (Director) and Climb Bio, Inc. (ELYM) (President & CEO, Director), among 7 companies in all. Across all of them we count 0 purchases worth $0 and 1 sale worth $20.2K reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a sale of 6,995 shares of ADC Therapeutics SA worth $20.2K, dated 2024-06-17. The first filing on our record is dated 2022-01-31 and the latest 2026-07-01.
ADC Therapeutics SA (ADCT)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2024-06-17 | S, sale reported on Form 4 | 6,995 | $20.2K | 2024-06-18 |
Cardinal Health INC (CAH)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
TERN
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Climb Bio, Inc. (ELYM)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
KDNY
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Autolus Therapeutics plc (AUTL)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Tango Therapeutics, Inc. (TNGX)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1656998) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms